Ketoconazole, 98%
Ketoconazole, 98%
Ketoconazole, 98%
Thermo Scientific Chemicals

Ketoconazole, 98%

Potent inhibitor of cytochrome P450c17 | CAS: 65277-42-1 | C26H28Cl2N4O4 | 534.452 g/mol
Have Questions?
Change viewbuttonViewtableView
Quantity:
5 g
25 g
This chemical may require us to obtain additional information for our regulatory and chemical compliance records. If required, we will contact you for this information once your order is placed.
Catalog number J63367.06
also known as J63367-06
Price (CNY)
-
Quantity:
5 g
Request bulk or custom format
Chemical Identifiers
CAS65277-42-1
IUPAC Name1-[4-(4-{[(2S,4R)-2-(2,4-dichlorophenyl)-2-[(1H-imidazol-1-yl)methyl]-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]ethan-1-one
Molecular FormulaC26H28Cl2N4O4
InChI KeyXMAYWYJOQHXEEK-ZEQKJWHPSA-N
SMILESCC(=O)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=CN=C3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1
View more
SpecificationsSpecification SheetSpecification Sheet
Appearance (Color)White
Assay from Supplier's CofA≥97.5%
FormPowder
Ketoconazole is used to treat candidiasis, chronic mucocutaneous candidiasis, oral thrush, candiduria, blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis, and paracoccidioidomycosis. Ketoconazole is an antifungal agent.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
Ketoconazole is used to treat candidiasis, chronic mucocutaneous candidiasis, oral thrush, candiduria, blastomycosis, coccidioidomycosis, histoplasmosis, chromomycosis, and paracoccidioidomycosis. Ketoconazole is an antifungal agent.

Solubility
Soluble in DMSO, ethanol, chloroform, water, and methanol.

Notes
Store away from strong oxidizing agents. Keep container tightly closed. Store in cool, dry conditions in well sealed containers.
RUO – Research Use Only

General References:

  1. Mikihisa Takano.; Risa Hasegawa.; Takeshi Fukuda.; Ryoko Yumoto.; Junya Nagai.; Teruo Murakami. Interaction with P-glycoprotein and transport of erythromycin, midazolam and ketoconazole in Caco-2 cells. European Journal of Pharmacology.1998, 358, (3), 289-294.
  2. Nick E Goeders.; Rachel L Peltier.; Glenn F Guerin. Ketoconazole reduces low dose cocaine self-administration in rats.Drug and Alcohol Dependence.1998, 53, (1), 67-77.